HealthEdge Software

The company is privately held and controlled by its board of directors and management, led by President and CEO Michael A. Greeley. Investment decisions around the product roadmap and acquisitions are made by the executive team, which is accountable to the venture capital investors that have provided equity funding, including GE Ventures, North Bridge Venture Partners, and Boston Millennia Partners.

HealthEdge sources acquisition targets through a combination of internal strategic planning and external relationships with investment banks and law firms that specialize in healthcare IT. The company has a stated strategy of acquiring complementary technology platforms and talent, as demonstrated by its purchase of Payformance in 2015 and Interopion in 2021.

HealthEdge is a software company, not a family office or venture firm. It is a venture-backed private company that sells its products to health insurance payers. Its investors include traditional venture capital firms. The company does not manage capital for external investors in a fund structure; instead, it generates revenue from annual software license fees, implementation services, and ongoing support.

HealthEdge does not participate in fund commitments. The company is a product business, not an investment firm. It makes direct corporate acquisitions of complementary software platforms, which are funded through a combination of venture equity, cash flow from operations, and debt financing.

HealthEdge targets mature, established software companies that have demonstrated product-market fit and are generating recurring revenue. Its acquisitions have been of companies with operating histories of at least five years and with technology that fills a gap in its health plan administrative platform.

HealthEdge focuses exclusively on the health insurance technology sector. It does not invest in or develop products for other segments of healthcare (such as provider-side EHRs, telehealth, or pharma) or for any non-healthcare industries. The company maintains a tight focus on payer administrative systems, including claims processing, membership, billing, care management, and analytics.

HealthEdge is a portfolio company of venture capital firms GE Ventures, North Bridge Venture Partners, and Boston Millennia Partners. The company's board includes representatives from these funds. No single family office or strategic corporate investor owns a controlling stake. The investors have provided equity financing across multiple rounds, the last disclosed being a $100 million Series D in 2018.